{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:16Z","timestamp":1787169556324,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Background &amp; objectives:<\/jats:italic>\n                      In this study, we aimed to investigate the relationship between serum TGF-\u03b21 and PDGF-B levels with the pathogenesis, clinical course and prognosis of adult Crimean-Congo hemorrhagic fever (CCHF) patients.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                      50 adult patients and 30 healthy individuals as a control group were included in the study, who were followed up and treated with the diagnosis of CCHF at the Atat\u00fcrk University Faculty of Medicine Infectious Diseases and Clinical Microbiology Clinic, between March 2017 and September 2019 in Eastern Anatolia Region in Turkey. Blood samples were taken from patients on the first day of their hospitalization and on the sixth day of their complaints. TGF-\u03b21 and serum PDGF-B levels were studied by ELISA method using commercial kits, from serum samples taken from CCHF patient group and individuals in healthy control group and stored at -80\u00b0C.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                      While the serum TGF- \u03b21 levels of patients with CCHF were found to be significantly higher on the sixth day of their complaints compared to the first day of hospitalization (42.33 \u00b1 15.42, 28.40 \u00b1 7.06, p = 0.001, respectively), the serum PGDF-B levels were found to be significantly lower on the sixth day of their complaints compared to those measured on the day of hospitalization (62.14 \u00b1 19.75, 93.96 \u00b1 20.02, respectively, p = 0.001).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Interpretation &amp; conclusion:<\/jats:italic>\n                      Serum TGF-\u03b21 levels are higher and PDGF-B levels are lower in CCHF patients with severe disease, indicating that serum TGF-\u03b21 and PDGF-B play an important role in the pathogenesis of CCHF.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0972-9062.337507","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T20:16:56Z","timestamp":1644437816000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Role of TGF-\u03b21 and PDGF-B in Crimean-Congo hemorrhagic fever in Eastern Anatolia Region in Turkey"],"prefix":"10.4103","volume":"59","author":[{"given":"Nazan","family":"Cinislio\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda","family":"A\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"K\u0131z\u0131ltun\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemalettin","family":"\u00d6zden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240830","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Erg\u00f6n\u00fcl","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R2-7-20240830","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res"},{"key":"R3-7-20240830","doi-asserted-by":"crossref","first-page":"a021873","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-\u03b2 and the TGF-\u03b2 Family: Context-Dependent Roles in Cell and Tissue Physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R4-7-20240830","doi-asserted-by":"crossref","first-page":"2b","DOI":"10.1016\/S0735-1097(86)80002-X","article-title":"Role of platelet activation and fibrin formation in thrombogenesis","volume":"8","author":"Vermylen","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"R5-7-20240830","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/clinids\/11.Supplement_4.S794","article-title":"The clinical pathology of Crimean-Congo hemorrhagic fever","volume":"11","author":"Swanepoel","year":"1989","journal-title":"Rev Infect Dis"},{"key":"R6-7-20240830","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","article-title":"Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited","volume":"12","author":"Ergonul","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R7-7-20240830","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4103\/0974-777X.83537","article-title":"An update on crimean congo hemorrhagic Fever","volume":"3","author":"Appannanavar","year":"2011","journal-title":"J Glob Infect Dis"},{"key":"R8-7-20240830","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jmv.24647","article-title":"The prognostic significance of serum TGF-\u03b21 levels in patients with Crimean-Congo hemorrhagic fever","volume":"89","author":"Yilmaz","year":"2017","journal-title":"J Med Virol"},{"key":"R9-7-20240830","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3906\/sag-1812-10","article-title":"The relationship with clinical course and prognosis of serum endothelin-1, angiopoietin-2, and tie-2 levels in Crimean-Congo hemorrhagic fever","volume":"49","author":"Kerget","year":"2019","journal-title":"Turk J Med Sci"},{"key":"R10-7-20240830","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/ndt\/gfl248","article-title":"Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure","volume":"21","author":"Ardalan","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R11-7-20240830","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2007.11.002","article-title":"Treatment of Crimean-Congo hemorrhagic fever","volume":"78","author":"Ergonul","year":"2008","journal-title":"Antiviral Res"},{"key":"R12-7-20240830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00441-003-0745-x","article-title":"Endothelial-pericyte interactions in angiogenesis","volume":"314","author":"Gerhardt","year":"2003","journal-title":"Cell Tissue Res"},{"key":"R13-7-20240830","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00005072-199704000-00012","article-title":"Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas","volume":"56","author":"Stiles","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"R14-7-20240830","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1038\/onc.2017.140","article-title":"Thrombospondin-4 mediates TGF-\u03b2-induced angiogenesis","volume":"36","author":"Muppala","year":"2017","journal-title":"Oncogene"},{"key":"R15-7-20240830","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R16-7-20240830","first-page":"71","article-title":"Sepsis Patogenezi","volume":"22","author":"Karaali","year":"2009","journal-title":"Klinik Geli\u015fim Dergisi"},{"key":"R17-7-20240830","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2011.11.027","article-title":"Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus","volume":"423","author":"Gupta","year":"2012","journal-title":"Virology"},{"key":"R18-7-20240830","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/520611","article-title":"Cytokine and chemokine expression in humans infected with Sudan Ebola virus","volume":"196","author":"Hutchinson","year":"2007","journal-title":"J Infect Dis"},{"key":"R19-7-20240830","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1128\/CVI.00530-09","article-title":"Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever","volume":"17","author":"Saksida","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R20-7-20240830","first-page":"303","article-title":"The role for transforming growth factor-beta (TGF-beta) in human cancer","volume":"10","author":"Gold","year":"1999","journal-title":"Crit Rev Oncog"},{"key":"R21-7-20240830","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18017\/iuitfd.78568","article-title":"Serum transforming growth factor beta 1 (TGF-\u03b21) levels in pancreatic adenocarcinoma patients","volume":"79","author":"Karabulut","year":"2016","journal-title":"J Ist Faculty Med"},{"key":"R22-7-20240830","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ajpath.2016.01.008","article-title":"Transforming Growth Factor-\u03b2 Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion","volume":"186","author":"Gupta","year":"2016","journal-title":"Am J Pathol"},{"key":"R23-7-20240830","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor beta in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"N Engl J Med"},{"key":"R24-7-20240830","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-7-20240830","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/bloodadvances.2017010868","article-title":"Platelet TGF-\u03b21 deficiency decreases liver fibrosis in a mouse model of liver injury","volume":"2","author":"Ghafoory","year":"2018","journal-title":"Blood Adv"},{"key":"R26-7-20240830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08977190701272784","article-title":"Prognostic value of platelet-derived growth factor in patients with severe sepsis","volume":"25","author":"Brueckmann","year":"2007","journal-title":"Growth Factors"},{"key":"R27-7-20240830","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.3485309","article-title":"Vasoconstriction: a new activity for platelet-derived growth factor","volume":"232","author":"Berk","year":"1986","journal-title":"Science"},{"key":"R28-7-20240830","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"key":"R29-7-20240830","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1093\/emboj\/cdf418","article-title":"Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy","volume":"21","author":"Enge","year":"2002","journal-title":"EMBO J"},{"key":"R30-7-20240830","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1101\/gad.8.16.1875","article-title":"Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities","volume":"8","author":"Leveen","year":"1994","journal-title":"Genes Dev"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.337507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:10:19Z","timestamp":1787166619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.337507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/0972-9062.337507","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}